Search Results - "Gorijala, Priyanka"
-
1
Gene co-expression changes underlying the functional connectomic alterations in Alzheimer's disease
Published in BMC medical genomics (23-04-2022)“…There is growing evidence indicating that a number of functional connectivity networks are disrupted at each stage of the full clinical Alzheimer's disease…”
Get full text
Journal Article -
2
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease
Published in Molecular neurodegeneration (03-01-2024)“…Triggering receptor expressed on myeloid cells 2 (TREM2) plays a critical role in microglial activation, survival, and apoptosis, as well as in Alzheimer's…”
Get full text
Journal Article -
3
Integrative analysis of eQTL and GWAS summary statistics reveals transcriptomic alteration in Alzheimer brains
Published in BMC medical genomics (23-04-2022)“…Large-scale genome-wide association studies have successfully identified many genetic variants significantly associated with Alzheimer's disease (AD), such as…”
Get full text
Journal Article -
4
TOPMed imputed genomics enhances genomic atlas of the human proteome in brain, cerebrospinal fluid, and plasma
Published in Scientific data (16-04-2024)“…Comprehensive expression quantitative trait loci studies have been instrumental for understanding tissue-specific gene regulation and pinpointing functional…”
Get full text
Journal Article -
5
Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson’s disease
Published in NPJ Parkinson's Disease (08-07-2023)“…Common and rare variants in the LRRK2 locus are associated with Parkinson’s disease (PD) risk, but the downstream effects of these variants on protein levels…”
Get full text
Journal Article -
6
Genetic architecture of plasma Alzheimer’s disease biomarkers
Published in Alzheimer's & dementia (01-06-2023)“…Background Case‐control genome‐wide association studies (GWAS) have identified loci associated with risk for Alzheimer disease (AD), but they require very…”
Get full text
Journal Article -
7
Genetic analyses of the plasma proteome and metabolome in the same cohort from participants with African and European ancestry identify ancestry‐specific AD risk associated molecular traits
Published in Alzheimer's & dementia (01-12-2023)“…Background Alzheimer disease (AD) has different prevalence across different ancestries. However, the genetic factors underlying AD pathogenesis between diverse…”
Get full text
Journal Article -
8
Alzheimer’s polygenic risk score is associated with Dementia and memory phenotypes in Down syndrome
Published in Alzheimer's & dementia (01-12-2023)“…Background Down syndrome (DS) is a complex neurological disorder manifested by triplication of chromosome 21, which includes the amyloid precursor protein…”
Get full text
Journal Article -
9
Genetic architecture of plasma Alzheimer disease biomarkers
Published in Human molecular genetics (20-07-2023)“…Abstract Genome-wide association studies (GWAS) of cerebrospinal fluid (CSF) Alzheimer’s Disease (AD) biomarker levels have identified novel genes implicated…”
Get full text
Journal Article -
10
CSF proteo‐genomic studies identify an interaction between LRRK2 genetic variants and GRN, GPNMB, CTSB, and ENTPD1
Published in Alzheimer's & dementia (01-06-2023)“…Background Parkinson’s disease (PD) is a movement disorder characterized by dopaminergic neurodegeneration in the substantia nigra of the brain. Another…”
Get full text
Journal Article -
11
Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease
Published in Acta neuropathologica (01-06-2024)“…Parkinson’s disease (PD) starts at the molecular and cellular level long before motor symptoms appear, yet there are no early-stage molecular biomarkers for…”
Get full text
Journal Article -
12
Integrative analysis of eQTL and GWAS summary statistics reveals novel genes related to Alzheimer's disease
Published in Alzheimer's & dementia (01-12-2021)“…Background Large‐scale genome wide association studies (GWASs) have identified many genetic variants associated with Alzheimer’s disease (AD) and related…”
Get full text
Journal Article -
13
A genetic and proteomic comparison of key AD biomarkers across tissues
Published in Alzheimer's & dementia (01-09-2024)“…INTRODUCTION Plasma has been proposed as an alternative to cerebrospinal fluid (CSF) for measuring Alzheimer's disease (AD) biomarkers, but no studies have…”
Get full text
Journal Article -
14
Genetic architecture of cerebrospinal fluid and brain metabolite levels and the genetic colocalization of metabolites with human traits
Published in Nature genetics (11-11-2024)“…Brain metabolism perturbation can contribute to traits and diseases. We conducted a genome-wide association study for cerebrospinal fluid (CSF) and brain…”
Get full text
Journal Article -
15
Proteo‐genomics of soluble TREM2 in cerebrospinal fluid provides novel insights for TREM2 biology and identifies novel modulators for Alzheimer’s disease
Published in Alzheimer's & dementia (01-12-2023)“…Background Triggering receptor expressed on myeloid cells 2 (TREM2) plays a critical role in microglial activation, survival, and apoptosis, as well as in…”
Get full text
Journal Article -
16
GWAS for CSF TREM2 levels identify new variants implicated on TREM2 biology and Alzheimer disease
Published in Alzheimer's & dementia (01-12-2022)“…Background It is demonstrated that the soluble TREM2 in the cerebrospinal fluid (CSF) is associated with Alzheimer disease (AD). Recent studies by our group…”
Get full text
Journal Article -
17
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease
Published in Nature genetics (11-11-2024)“…The integration of quantitative trait loci (QTLs) with disease genome-wide association studies (GWASs) has proven successful in prioritizing candidate genes at…”
Get full text
Journal Article -
18
Proteome Wide Association Studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson’s disease
Published in Alzheimer's & dementia (01-12-2023)“…Background Leucine‐rich repeat kinase 2 (LRRK2) common gene variants (tagged by rs76904798) are associated with Parkinson’s disease (PD) risk. In a previous…”
Get full text
Journal Article -
19
Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome
Published in Alzheimer's & dementia (01-02-2024)“…INTRODUCTION This study aimed to investigate the influence of the overall Alzheimer's disease (AD) genetic architecture on Down syndrome (DS) status, cognitive…”
Get full text
Journal Article -
20
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Published in Genome medicine (04-10-2023)“…Genome-wide association studies (GWAS) of Alzheimer's disease (AD) have identified several risk loci, but many remain unknown. Cerebrospinal fluid (CSF)…”
Get full text
Journal Article